Fig. 5From: Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeuticsExisting compounds that have been investigated thus far in animal studies and clinical trials (circle) or have FDA-approved formulations (rectangle) by mechanism of impact on OPC proliferation, OL differentiation/maturation, and/or myelinationBack to article page